Medical/Pharmaceuticals News & Press Release Distribution

Suvoda Launches eCOA-Specific Language and Design Toolkit as Solution Moves to Second Phase of Early Adopter Program

Practical, innovative functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience. PHILADELPHIA, Dec. 7, 2022 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic ar...

2022-12-07 08:00 3081

Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific

HCP Access is selective as nearly half meet with only one company monthly SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the latestVeeva Pulse Field Trends Report , the largest glob...

2022-12-07 08:00 4624

Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific

Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering

SYDNEY, Dec. 7, 2022 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today commenced its previously announced backstopped rights offering to raise gross proceeds of approximatelyUS$4.0 million (the "Rights Offering"). Under the terms of the Rights O...

2022-12-07 07:00 4304

New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances

SAN FRANCISCO, Dec. 7, 2022 /PRNewswire/ -- The diaTribe Foundation, Advanced Technologies & Treatments for Diabetes (ATTD), and the Time in Range Coalition announced today a new international consensus regarding continuous glucose monitoring (CGM) metrics for clinical trials to help accelerate t...

2022-12-07 01:26 2721

Healthcare Summit Convened to Address Maternal-Fetal Outcomes in Sub-Saharan Africa

ROCKVILLE, Md., Dec. 6, 2022 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization and Kenya Healthcare Federation, a membership-based organization that serves as the umbrella body forKenya's Private Health Sector, hosted a maternal and fetal ultrasound summit onNov....

2022-12-06 23:00 2688

Turn Biotechnologies Changes Paradigm in Skin Rejuvenation

* Data unveiled at four industry conferences suggest a single ERA treatment may be more effective than combination therapies used today * Biomarker analysis demonstrates ERA's regenerative impact on fibroblast proliferation, collagen VII production * eTurna™ lipid-based delivery platform p...

2022-12-06 22:00 5097

Turn Biotechnologies Changes Paradigm in Skin Rejuvenation

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022

WASHINGTON, Dec. 6, 2022 /PRNewswire/ -- TIANGEN, a high-tech biological enterprise, demonstrated its revolutionary nucleic acid extraction solution at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), fromDec 4 to...

2022-12-06 21:04 2668

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022

Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF)

* Akeso Inc. to out-license to Summit Therapeutics exclusive rights to ivonescimab (PD-1/VEGF) for the development and commercialization inthe United States, Canada, Europe, and Japan. Akeso Inc. will retain development and commercialization rights for the rest of the world includingChina. * ...

2022-12-06 21:01 3827

CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL

Corvia® Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., Dec. 6, 2022 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a globa...

2022-12-06 20:04 2189

CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL

Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030

* Delivers new drug for two consecutive years by obtaining product license on "Envlo", Korea's 36th new drug from the Ministry of Food and Drug Safety * Plans to enter the type 2 diabetes global market worth $71.4 billion * Provides new and broad treatment options for patients with insufficie...

2022-12-06 20:00 2437

Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data

LONDON, Dec. 6, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the inclusion of linked specialty pharmacy claims data within real world datasolutions. The new U.S. dataset will ex...

2022-12-06 18:20 3027

GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio, announced MFDS clearance of its phase I/II clinical trial application for innovative antibody drug program (SLC-3010) . GenScript ProBio extended congratulations on this. SinceDecember 2019, GenSc...

2022-12-06 17:14 4064

University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

TOKYO, Dec. 6, 2022 /PRNewswire/ -- - World's First Research into Relationship between Rich-in-Biodiversity Garden Greenery and Health/Well-being - The University of Tokyo's Graduate School of Agricultural and Life Sciences (GSALS) and Sekisui House, Ltd. launched a joint research project on b...

2022-12-06 14:00 1909

BSR KOREA Introduces "Healcerion Co., Ltd." as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-06 11:00 3585

BSR KOREA Introduces "CORE VALUE" as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-06 11:00 3004

Neeuro and Institute of Mental Health Launch Home-Based Attention Training Programme

SINGAPORE, Dec. 6, 2022 /PRNewswire/ -- Neeuro, a Singapore tech start-up and Agency for Science, Technology and Research (A*STAR) spinoff, and the Institute of Mental Health (IMH) launched Cogo as a complementary home-based attention training programme this month. This solution aims to improve i...

2022-12-06 09:00 7680

Neeuro and Institute of Mental Health Launch Home-Based Attention Training Programme

SK Biopharmaceuticals Wins Export Award for Cenobamate

SK Biopharmaceuticals receives the '$100 million Export Tower' award, becoming the first Korean pharmacompany to earn this prestige with a single innovative anti-seizure medication, cenobamate Cenobamate achieves over $100 million in exports in two years after launching in the U.S. andEurope – t...

2022-12-06 08:00 2666

Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors

YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the appointments...

2022-12-05 22:33 3019

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

HAIKOU, China, Dec. 5, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced the Acquisition of Dry Eye Disease...

2022-12-05 21:00 3601

Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine®

HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ -- apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering mixed reality software device enabling surgeons to plan complex procedures using the power of immersive 3D...

2022-12-05 21:00 3125